Sort
11,323 grants matching “glioblastoma”
Interaction of ASIC and BK channels and its role in glial proliferation
$320,657Elena Petroff · Montclair State University · R15 · FY2011 · NS
Project 3: Notch signaling in oHSV therapy for GBM
$320,643Balveen Kaur · Brigham And Women'S Hospital · P01 · FY2020 · CA
Project 3: Notch signaling in oHSV therapy for GBM
$320,643Balveen Kaur · Brigham And Women'S Hospital · P01 · FY2021 · CA
B7H1 Mediated Immunosuppression in Glioma
$320,588Andrew T Parsa · Northwestern University At Chicago · R01 · FY2013 · CA
Modulation of Oncogenic Signaling in Glioblastomas
$320,588Shi-Yuan Cheng · Northwestern University At Chicago · R01 · FY2015 · CA
Modulation of Oncogenic Signaling in Glioblastomas
$320,588Shi-Yuan Cheng · Northwestern University At Chicago · R01 · FY2012 · CA
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM
$320,588Russell O Pieper · University Of California, San Francisco · R01 · FY2010 · CA
Modulation of Oncogenic Signaling in Glioblastomas
$320,588Shi-Yuan Cheng · Northwestern University At Chicago · R01 · FY2016 · CA
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM
$320,588Russell O Pieper · University Of California, San Francisco · R01 · FY2009 · CA
CERT Imaging of Cancer
$320,571Daniel F Gochberg · Vanderbilt University · R01 · FY2014 · CA
The San Francisco Bay Area Adult Glioma Survival Study
$320,560Margaret R. Wrensch · University Of California, San Francisco · P50 · FY2009 · CA
Cath B and uPAR si RNA constructs regressed glioma growth
$320,546John P O'Bryan · University Of Illinois At Chicago · R01 · FY2014 · CA
ATM as target for malignant glioma radiosensitization.
$320,491Kristoffer Valerie · Virginia Commonwealth University · R01 · FY2011 · NS
ATM as target for malignant glioma radiosensitization.
$320,491Kristoffer Valerie · Virginia Commonwealth University · R01 · FY2012 · NS
Co-targeting mTOR and YAP signaling in glioblastoma
$320,490Joseph F Gera · Brentwood Biomedical Research Institute · R01 · FY2018 · CA
Phase I Study of Dendritic Cell Immunotherapy
$320,250University Of California Los Angeles · R21 · FY2002 · CA
Clinical Neuroimmunology of CCL3 in Brain Tumors
$320,248Michael D Gunn · Duke University · R01 · FY2025 · CA
Advanced MRI methods for detecting pseudo-progression of glioblastomas
$320,232Ronald L Wolf · University Of Pennsylvania · R21 · FY2014 · CA
Radiation-Induced Crosstalk of Immune and Glioma Stem Cells
$320,209Ichiro Nakano · University Of Alabama At Birmingham · R01 · FY2019 · NS
Co-targeting mTOR and YAP signaling in glioblastoma
$320,054Joseph F Gera · Greater Los Angeles Veterans Research And Education Foundation · R01 · FY2022 · CA
The role of a histone H4 phosphorylation in drug resistance
$320,027Zhiguo Zhang · Mayo Clinic Rochester · R01 · FY2014 · CA
Mechanisms of acquired temozolomide resistance in glioblastoma multiforme
$320,027Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2014 · CA
Non-canonical signal pathway for Crk in breast cancer
$320,027Raymond B Birge · Rbhs-New Jersey Medical School · R01 · FY2014 · CA
Molecular mechanisms of GBM radioresistance and strategies for radiosensitization
$320,027Sandeep Burma · Ut Southwestern Medical Center · R01 · FY2014 · CA
Defining the metabolic phenotype of low grade gliomas in vivo
$320,027Elizabeth A Maher · Ut Southwestern Medical Center · R01 · FY2014 · CA